Results

1. Fundamental physiology and target discovery in type 2 diabetes: Science at the interface of academia and pharma - Oxford Talks

Toggle navigation. Fundamental physiology and target discovery in type 2 diabetes: Science at the interface of academia and pharma.

talks.ox.ac.uk/talks/id/99c6c9f9-57e7-4851-9515-243dab8c985b/- 10k - Cached

2. Is there a healthy future for Big Pharma? | University of Oxford Podcasts - Audio and Video Lectures

Is there a healthy future for Big Pharma? ... And what are the ethical boundaries in the relationship between medical practitioners and pharma companies?

podcasts.ox.ac.uk/there-healthy-future-big-pharma-0- 32k - 29 Jun 2022 - Cached

3. BridgeBio Pharma: Turning translational academic research into medicines for patients with genetic diseases - Oxford Talks

Toggle navigation. BridgeBio Pharma: Turning translational academic research into medicines for patients with genetic diseases. ... Cost: Free. Audience: Members of the University of Oxford and the Biotech/Pharma industry.

talks.ox.ac.uk/talks/id/e7064f2f-c603-4095-b0da-b200b0a7d8fd/- 14k - Cached

4. Visual materiality of corporate science: asbestos, tobacco, pharma, and food - Oxford Talks

Toggle navigation. Visual materiality of corporate science: asbestos, tobacco, pharma, and food.

talks.ox.ac.uk/talks/id/8381a355-c021-4863-b5bf-d0b666741c81/- 10k - Cached

5. How do you get from an idea to a marketed drug? Part 4: Engaging with pharma - Oxford Talks

Part 4: Engaging with pharma. The TRO invites you to a weekly series of webinars to explore the key steps in the discovery and development of new medicines, helping you to ... Week 3 (Nov 3rd ): Drug development. Week 4 (Nov 10th): Engaging with pharma.

talks.ox.ac.uk/talks/id/41a83567-ed87-4fa7-8f48-09b0fda33e90/- 14k - Cached

6. Pharma R&D: from benchwork to project management - Oxford Talks

Toggle navigation. Pharma R&D: from benchwork to project management. Are you interested in Pharma R&D?

talks.ox.ac.uk/talks/id/3c2ec4ac-4c89-40d0-8968-13aceb50aea5/- 15k - Cached

7. Is there a healthy future for Big Pharma? | University of Oxford Podcasts - Audio and Video Lectures

Is there a healthy future for Big Pharma?

podcasts.ox.ac.uk/there-healthy-future-big-pharma- 32k - 29 Jun 2022 - Cached

8. Oxford spinout OMass Technologies provides native mass spectrometry to pharma and biotech | University of Oxford

Image credit: Isis Innovation. Published. 14 Jun 2016. Share This. Oxford spinout OMass Technologies provides native mass spectrometry to pharma and biotech.

www.ox.ac.uk/news/2016-06-14-oxford-spinout-omass-technologies-provides-native-mass-spectrometry-pharma-and- 52k - 30 Jun 2022 - Cached

9. Bryn Roberts - Kellogg College

» Our People » Bryn Roberts. Bryn Roberts’s background is in Data Science and he has a PhD in Pharmacology. His interests lie in AI and machine learning, systems biology and scientific software development. He is an Associated Faculty member

www.kellogg.ox.ac.uk/our-people/bryn-roberts/- 32k - 27 Jan 2021 - Cached

10. Why Mark Zuckerberg was right to vaccinate his daughter | University of Oxford

Share This. Why Mark Zuckerberg was right to vaccinate his daughter. Anita Milicic, Senior scientist, University of Oxford. Human papilloma virus (HPV). (Credit: Shutterstock). Facebook co-founder Mark Zuckerberg recently posted a photo on the

www.ox.ac.uk/research/why-mark-zuckerberg-was-right-vaccinate-his-daughter- 50k - 16 Jun 2022 - Cached